Source Administration Set (SAS) used with the Medrad Intego PET Infusion System, Sterile Catalog...
FDA Device Recall #Z-0910-2023 — Class II — November 30, 2022
Recall Summary
| Recall Number | Z-0910-2023 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 30, 2022 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Bayer Medical Care, Inc. |
| Location | Indianola, PA |
| Product Type | Devices |
| Quantity | 2840 units |
Product Description
Source Administration Set (SAS) used with the Medrad Intego PET Infusion System, Sterile Catalog number: INT CSS Affected material number: 86566621 Intended to deliver accurate doses of 18F Fluorodeoxyglucose (FDG) or 18F Sodium Fluoride (NaF) radiopharmaceuticals and commonly used flushing solutions to patients during molecular imaging (PET Positron Emission Tomography - nuclear medicine) diagnostic procedures.
Reason for Recall
Black specks may be present on the packaged needles
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of AZ, IN, MN, NY, OH, TX, VA and the country of China.
Lot / Code Information
UDI: (01)00616258021478(11)201209(17)231209(10)60272154 Batch number: 60272154 Expiration date: December 9, 2023
Other Recalls from Bayer Medical Care, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2296-2026 | Class II | Avanta Multi-Patient Administration Tube Sets (... | Apr 24, 2026 |
| Z-0199-2022 | Class II | The MEDRAD Twist & Go Disposable Syringe 150 mL... | Sep 14, 2021 |
| Z-0483-2021 | Class II | Brand Name: MEDRAD Stellant FLEX Syringe Kits ... | Oct 5, 2020 |
| Z-0745-2019 | Class II | MAVIG Portegra or Portegra2 Overhead Counterpoi... | Dec 14, 2018 |
| Z-0097-2019 | Class II | Codan Filter (Codan catalog number BC 693) used... | Sep 7, 2018 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.